If you have sufficiently advanced liver scarring you should consider an NIH
trial called HALT-C, which is being done across the country. this trial will
provide medication (PEG + ribavirin) to see if you can become a responder,
but if you do not, will offer a randomized choice between low-dose PEG and
observation for 3.5 years. you can consult the NIH web page to learn further
If you have mild disease, then you may wish to wait for better therapies in
a few years, or you can have your doctor contact the insurer for approval.